TY  - JOUR 
AU  - Schmidinger, M.
AU  - Bamias, A.
AU  - Procopio, G.
AU  - Hawkins, R.
AU  - Sánchez, AR.
AU  - Vázquez Estévez, Sergio
AU  - Srihari, N.
AU  - Kalofonos, H.
AU  - Bono, P.
AU  - Pisal, CB.
AU  - Hirschberg, Y.
AU  - Dezzani, L.
AU  - Ahmad, Q.
AU  - Jonasch, E.
AU  - Group, PRINCIPAL Study
PY  - 2019
SN  - 1083-7159
UR  - http://hdl.handle.net/20.500.11940/16083
AB  - BACKGROUND: Real-world data are essential to accurately assessing efficacy and toxicity of approved agents in everyday practice. PRINCIPAL, a prospective, observational study, was designed to confirm the real-world safety and efficacy of pazopanib in...
LA  - eng
KW  - Adult
KW  - Carcinoma
KW  - Middle Aged
KW  - Sulfonamides
KW  - Follow-Up Studies
KW  - Kidney Neoplasms
KW  - Quality of Life
KW  - Survival Rate
KW  - Angiogenesis Inhibitors
KW  - Pyrimidines
KW  - Humans
KW  - Treatment Outcome
KW  - Young Adult
KW  - Prospective Studies
KW  - Aged
KW  - Prognosis
TI  - Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
DO  - 10.1634/theoncologist.2018-0787
T2  - ONCOLOGIST
M2  - 988
KW  - HULA
VL  - 24
ER  -